Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Erin Wright is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/31/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/17/2024 | BTSG | Buy Now | BrightSpring Health | $18.09 | 10.56% | Erin Wright 66% | $19 → $20 | Maintains | Overweight | Get Alert |
| 12/17/2024 | DGX | Buy Now | Quest Diagnostics | $170.50 | 0.88% | Erin Wright 66% | $145 → $172 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/29/2024 | PDCO | Buy Now | Patterson Cos | $31.24 | -13.57% | Erin Wright 66% | $28 → $27 | Maintains | Equal-Weight | Get Alert |
| 02/28/2024 | PDCO | Buy Now | Patterson Cos | $31.24 | -3.97% | Erin Wright 66% | $32 → $30 | Maintains | Equal-Weight | Get Alert |
| 02/20/2024 | BTSG | Buy Now | BrightSpring Health | $18.09 | -0.5% | Erin Wright 66% | → $18 | Initiates | → Overweight | Get Alert |
